Zio ECG Utilization Software (ZEUS) System vs Study Watch
AI Verdict
Choose Zio ECG Utilization Software (ZEUS) System if…
Choose the Zio ECG Utilization Software (ZEUS) System if your primary objective is the clinical diagnosis and ongoing management of cardiac arrhythmias in patients. This AI-powered, cloud-based platform is ideal for physicians needing comprehensive, deep-learned ECG analysis from continuous wearable monitoring to inform treatment decisions and integrate with existing EHR systems.
View Zio ECG Utilization Software (ZEUS) System →Choose Study Watch if…
Choose the Verily Study Watch if you are conducting clinical research that requires continuous, multi-modal physiological data collection from study participants. This prescription-only wearable is specifically designed for research settings, offering diverse data points like ECG, heart rate, and movement over an extended period for in-depth analysis within a secure cloud platform.
View Study Watch →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Zio ECG Utilization Software (ZEUS) System | Study Watch |
|---|---|---|
| Deployment | Cloud-based. | The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio ECG Utilization Software (ZEUS) SystemTool A offers a comprehensive ecosystem with a dedicated web portal (ZioSuite) and mobile application for healthcare professionals, designed for ease of use in managing patients and interpreting diagnostic reports. Its patient-centric monitor design also promotes high compliance and comfortable wear, contributing to a smoother overall user experience for both clinicians and patients in a diagnostic setting.
Clinical Value
Zio ECG Utilization Software (ZEUS) SystemTool A is explicitly designed and clinically validated for aiding physicians in the diagnosis and management of cardiac arrhythmias, demonstrating superior diagnostic yield and improved patient outcomes in multiple large-scale studies compared to traditional monitoring. While Tool B collects valuable physiological data and has FDA clearance for ECG, its primary stated application is clinical research, with less direct evidence of immediate clinical utility for routine diagnostic care.
Pricing & Value
Zio ECG Utilization Software (ZEUS) SystemWhile both tools lack publicly available pricing, Tool A has established Category I CPT codes for reimbursement, indicating a clear pathway for billing and demonstrating health-economic value through reduced retesting and healthcare expenditures in clinical settings. Tool B's pricing is tied to clinical research and partnerships, lacking a direct, transparent value proposition for routine clinical care reimbursement.
Enterprise Readiness
Zio ECG Utilization Software (ZEUS) SystemTool A demonstrates strong enterprise readiness with proven, seamless HL7-based EHR integration across major systems, including Epic, and a clear track record of HIPAA compliance and BAA handling. While Tool B also offers cloud deployment and adherence to security standards, the ongoing lawsuit alleging HIPAA violations and data misuse, despite Verily's denials, presents a significant potential risk and concern for enterprise partners.
Innovation
TieBoth tools demonstrate significant innovation in their respective domains. Tool A excels with its FDA-cleared, deep-learned AI algorithm for highly accurate cardiac arrhythmia detection and diagnosis over extended periods, leveraging a vast dataset. Tool B innovates through its multi-sensor physiological monitoring capabilities, robust device design for clinical research, and strategic partnerships to integrate diverse wearable data for comprehensive health insights in research.
Support & Docs
Zio ECG Utilization Software (ZEUS) SystemTool A provides clear and accessible support for healthcare professionals, including 24/7 customer care for clinical and billing inquiries, a dedicated clinical resource center with extensive documentation, and patient-facing resources. Tool B, being primarily for clinical research and partnerships, does not publicly detail a comparable level of direct support and documentation for a broad user base.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Zio ECG Utilization Software (ZEUS) System | Study Watch |
|---|---|---|
| Product Name | Zio ECG Utilization Software (ZEUS) System | Study Watch |
| Company | iRhythm Technologies | Verily Life Sciences |
| Primary Purpose | Analyzes continuous ECG data from wearable Zio monitors to aid physicians in the diagnosis and management of cardiac arrhythmias. | Prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research. |
| Core Data Analysis Method | AI algorithm for arrhythmia detection and classification; proprietary deep-learned algorithms | Algorithms and machine learning |
| Maximum Continuous Monitoring/Battery Life | Up to 14 days (continuous ECG data analysis) | Up to one week (long battery life) |
| EHR Integration | HL7-based EHR integration | Not specified |
Videos
Demos, reviews, and walkthroughs featuring Zio ECG Utilization Software (ZEUS) System and Study Watch.
Frequently Asked Questions
More Comparisons
More matchups featuring Zio ECG Utilization Software (ZEUS) System or Study Watch
Backers
Who funded each tool's parent company.